96232-71-2 Usage
General Description
METHYL 4,5-DIBROMO-3-HYDROXYTHIOPHENE-2-CARBOXYLATE is a chemical compound that belongs to the thiophene family. It is a derivative of thiophene, a five-membered heterocyclic compound containing a sulfur atom. The presence of two bromine atoms and a carboxylate group in the chemical structure gives it unique properties and potential applications in organic synthesis, pharmaceuticals, and agrochemicals. METHYL 4,5-DIBROMO-3-HYDROXYTHIOPHENE-2-CARBOXYLATE is commonly used as an intermediate in the production of various functional materials, including pharmaceutical ingredients and agrochemicals. It also has potential applications in the field of organic electronics due to its electronic properties. Additionally, its structure and properties make it useful in the development of new chemical compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 96232-71-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,2,3 and 2 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 96232-71:
(7*9)+(6*6)+(5*2)+(4*3)+(3*2)+(2*7)+(1*1)=142
142 % 10 = 2
So 96232-71-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H4Br2O3S/c1-11-6(10)4-3(9)2(7)5(8)12-4/h9H,1H3
96232-71-2Relevant articles and documents
N-1H-Tetrazol-5-yl-(5-Ring)-carboxamide-derivatives, a process for their manufacture, and the use thereof
-
, (2008/06/13)
-
N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof
-
, (2008/06/13)
The present invention is for compounds having the formula of N-1H-tetrazol-5-yl-2-thiophenecarboxamides, N-1H-tetrazol-5-yl-2-pyrrolecarboxamides, N-1H-tetrazol-5-yl-2-furancarboxamides or analogs of each of the carboxamides. The compounds are useful for the treatment of allergic or inflammatory conditions or diseases. Thus, pharmaceutical compositions and methods of use are also the invention. Processes of preparation for the compounds are also the invention.